{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:04:05Z","timestamp":1784347445210,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.msard.2025.106831","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:16:27Z","timestamp":1762308987000},"page":"106831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Perceived impact of disease modifying therapies on pain in people with multiple sclerosis: A mixed methods study"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6579-1136","authenticated-orcid":false,"given":"Mohammed Suleiman","family":"Obsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0942-0469","authenticated-orcid":false,"given":"Alice","family":"Saul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4336-0095","authenticated-orcid":false,"given":"Laura L","family":"Laslett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5990-3904","authenticated-orcid":false,"given":"Kristen","family":"Lefever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1820-6758","authenticated-orcid":false,"given":"Julie","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2807-0070","authenticated-orcid":false,"given":"Bruce V","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-7472","authenticated-orcid":false,"given":"Ingrid","family":"van der Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106831_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.808370","article-title":"Adverse drug reactions with drugs used in multiple sclerosis: an analysis from the Italian pharmacovigilance database","volume":"13","author":"Barbieri","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.msard.2025.106831_bib0002","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jns.2016.07.026","article-title":"Severe articular and musculoskeletal pain: an unexpected side effect of dimethyl-fumarate therapy for multiple sclerosis","volume":"369","author":"Bernardini","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.msard.2025.106831_bib0003","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/pme.12731","article-title":"The prevalence of pain in adults with multiple sclerosis: a multicenter cross-sectional survey","volume":"16","author":"Drulovic","year":"2015","journal-title":"Pain. Med."},{"key":"10.1016\/j.msard.2025.106831_bib0004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2147\/JPR.S230680","article-title":"Interferon-beta-induced headache in patients with multiple sclerosis: frequency and characterization","author":"Elmazny","year":"2020","journal-title":"J. Pain. Res."},{"key":"10.1016\/j.msard.2025.106831_bib0005","series-title":"Qualitative Analysis","author":"Ezzy","year":"2013"},{"key":"10.1016\/j.msard.2025.106831_bib0006","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10072-017-3217-x","article-title":"Systematic assessment and characterization of chronic pain in multiple sclerosis patients","volume":"39","author":"Ferraro","year":"2018","journal-title":"Neurol. Sci."},{"issue":"5","key":"10.1016\/j.msard.2025.106831_bib0007","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.pain.2012.12.002","article-title":"Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis","volume":"154","author":"Foley","year":"2013","journal-title":"Pain\u00ae"},{"key":"10.1016\/j.msard.2025.106831_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103837","article-title":"The influence of disease-modifying therapy on hidden disability burden in people with newly diagnosed relapsing-remitting multiple sclerosis","volume":"63","author":"Glasmacher","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1\u20132","key":"10.1016\/j.msard.2025.106831_bib0009","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jneuroim.2012.07.014","article-title":"The switch between relapse and remission in multiple sclerosis: continuous inflammatory response balanced by Th1 suppression and neurotrophic factors","volume":"252","author":"Gurevich","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.msard.2025.106831_bib0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/qjmed\/hch105","article-title":"What drives quality of life in multiple sclerosis?","volume":"97","author":"Hemmett","year":"2004","journal-title":"QJM."},{"issue":"2","key":"10.1016\/j.msard.2025.106831_bib0011","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbadis.2010.07.019","article-title":"The blood\u2013brain barrier, chemokines and multiple sclerosis","volume":"1812","author":"Holman","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"issue":"12","key":"10.1016\/j.msard.2025.106831_bib0012","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1177\/1352458509347150","article-title":"Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients","volume":"15","author":"Honarmand","year":"2009","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106831_bib0013","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.msard.2019.01.002","article-title":"Frequency, type, distribution of pain and related factors in persons with multiple sclerosis","volume":"28","author":"Kahraman","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106831_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-020-01882-2","article-title":"Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States","volume":"20","author":"Kern","year":"2020","journal-title":"BMC. Neurol."},{"key":"10.1016\/j.msard.2025.106831_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-013-0195-3","article-title":"Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models","volume":"22","author":"Khan","year":"2014","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.msard.2025.106831_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2377-13-37","article-title":"Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis","volume":"13","author":"Learmonth","year":"2013","journal-title":"BMC. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2025.106831_bib0017","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/jamaneurol.2015.3977","article-title":"Effect of multiple sclerosis disease-modifying therapies on B cells and humoral immunity","volume":"73","author":"Longbrake","year":"2016","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106831_bib0018","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2015.08.016","article-title":"Role of inflammation and apoptosis in multiple sclerosis: comparative analysis between the periphery and the central nervous system","volume":"287","author":"Macchi","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"13","key":"10.1016\/j.msard.2025.106831_bib0019","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample size in qualitative interview studies: guided by information power","volume":"26","author":"Malterud","year":"2016","journal-title":"Qual. Health Res."},{"key":"10.1016\/j.msard.2025.106831_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1243589","article-title":"Switching to second line MS disease-modifying therapies is associated with decreased relapse rate","volume":"14","author":"Marriott","year":"2023","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2025.106831_bib0023","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad. Med."},{"issue":"8","key":"10.1016\/j.msard.2025.106831_bib0024","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2174\/1570159X19666211101142115","article-title":"Interferon-Beta Injection in Multiple Sclerosis Patients Related to the Induction of Headache and Flu-Like Pain Symptoms: a Systematic Review and Meta-Analysis of Randomised Controlled Trials","volume":"20","author":"Pereira","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.msard.2025.106831_bib0025","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00415-018-8758-2","article-title":"Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria","volume":"265","author":"Solaro","year":"2018","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2025.106831_bib0026","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int. J. Qual. Health Care"},{"key":"10.1016\/j.msard.2025.106831_bib0027","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00415-012-6579-2","article-title":"A mechanism-based classification of pain in multiple sclerosis","volume":"260","author":"Truini","year":"2013","journal-title":"J. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:38:06Z","timestamp":1784345886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825005735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"alternative-id":["S2211034825005735"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106831","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perceived impact of disease modifying therapies on pain in people with multiple sclerosis: A mixed methods study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106831"}}